Use of Play Dough in Children Receiving Nebulizer Therapy
The Effect of Playing Dough on Children's Adaptation to Nebulizer Treatment Children 3-6 Years Old Child Service: Randomized Controlled Study
1 other identifier
interventional
80
1 country
1
Brief Summary
The aim of this study is to present the results of the effect of playing with play dough on treatment compliance in children aged 3-6 years receiving nebulizer therapy. In the randomized controlled study, 80 children who were hospitalized in the pediatric ward of a public hospital and met the inclusion criteria were equally divided into 2 groups. Play dough was played while receiving nebulizer therapy for the children in group 1 (research group). Play dough was not used for the children in the 2nd group. The compliance of the children in the two groups to the treatment was evaluated with the Child's Adherence to Nebulizer Treatment Evaluation Form (CANTEF).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2022
CompletedFirst Submitted
Initial submission to the registry
February 24, 2023
CompletedFirst Posted
Study publicly available on registry
March 22, 2023
CompletedMay 3, 2023
April 1, 2023
5 months
February 24, 2023
April 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identifying the child's adherence with nebulizer therapy
The child's behavior during nebulizer therapy was assessed using the Child's Nebulizer Treatment Compliance Evaluation Form. In this form, body temperature, pulse, respiratory rate, saturation, respiratory function, and behaviors were evaluated. When assessing behaviors, she is "irritable", "crying", "not allowing her vital signs to be taken", "very active, not sitting up", "wanting to go to her parent's lap", "yelling and screaming" ', 'not communicating with the researcher', 'removing the mask from his face' criteria were evaluated. The answers were evaluated as "yes" or "no". Children with a high rate of yes answers were considered non-adherent to treatment.
Children's behavior and vital signs were evaluated 5 minutes before the treatment. evaluated for 15 minutes during treatment. Evaluation was done every 5 minutes.
Study Arms (2)
Play Dough Group
EXPERIMENTALPlay dough was played while receiving nebulizer therapy for the children in play dough group.
Routine Treatment Group
NO INTERVENTIONPlay dough was not used for the children in the routine treatment group. Routine nebulizer treatment was applied to this group.
Interventions
In the play dough group, play dough was used during the treatment of children receiving nebulizer therapy.
Eligibility Criteria
You may qualify if:
- Parent's consent to participate in the study
- Stable clinical status
- The child's motor skills should be at a level to be able to play with play dough and should be developed according to his age,
- The child's ability to speak and understand Turkish.
You may not qualify if:
- Any physical or mental disability that prevents the child from playing with play dough
- The child has a behavior disorder or disease that causes maladaptive behavior
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maltepe University
Istanbul, Maltepe, Turkey (Türkiye)
Related Publications (10)
Ari A. Drug delivery interfaces: A way to optimize inhalation therapy in spontaneously breathing children. World J Clin Pediatr. 2016 Aug 8;5(3):281-7. doi: 10.5409/wjcp.v5.i3.281. eCollection 2016 Aug 8.
PMID: 27610343BACKGROUNDCaleffi CC, Rocha PK, Anders JC, Souza AI, Burciaga VB, Serapiao Lda S. Contribution of structured therapeutic play in a nursing care model for hospitalised children. Rev Gaucha Enferm. 2016 Jun;37(2):e58131. doi: 10.1590/1983-1447.2016.02.58131. Epub 2016 May 31. English, Portuguese.
PMID: 27253598BACKGROUNDDiBlasi RM. Clinical Controversies in Aerosol Therapy for Infants and Children. Respir Care. 2015 Jun;60(6):894-914; discussion 914-6. doi: 10.4187/respcare.04137.
PMID: 26070582BACKGROUNDGoralski JL, Davis SD. Breathing easier: addressing the challenges of aerosolizing medications to infants and preschoolers. Respir Med. 2014 Aug;108(8):1069-74. doi: 10.1016/j.rmed.2014.06.004. Epub 2014 Jun 25.
PMID: 25012949BACKGROUNDHoiseth M, Keitsch MM, Holm Hopperstad M. Interactions between caregivers and young children: exploring pedagogical tact in nebulizer treatment. Qual Health Res. 2014 Dec;24(12):1622-34. doi: 10.1177/1049732314549017. Epub 2014 Sep 5.
PMID: 25192760BACKGROUNDKoller D, Goldman RD. Distraction techniques for children undergoing procedures: a critical review of pediatric research. J Pediatr Nurs. 2012 Dec;27(6):652-81. doi: 10.1016/j.pedn.2011.08.001. Epub 2011 Oct 13.
PMID: 21925588BACKGROUNDLima KY, Santos VE. [Play as a care strategy for children with cancer]. Rev Gaucha Enferm. 2015 Jun;36(2):76-81. doi: 10.1590/1983-1447.2015.02.51514. Portuguese.
PMID: 26334412BACKGROUNDShinta Devi NLP, Nurhaeni N, Hayati H. Effect of Audiovisual Distraction on Distress and Oxygenation Status in Children Receiving Aerosol Therapy. Compr Child Adolesc Nurs. 2017;40(sup1):14-21. doi: 10.1080/24694193.2017.1386966.
PMID: 29166200BACKGROUNDStewart MW. Therapeutic Play Intervention. J Perianesth Nurs. 2016 Oct;31(5):452-6. doi: 10.1016/j.jopan.2016.07.001. No abstract available.
PMID: 27667353BACKGROUNDAri A. A path to successful patient outcomes through aerosol drug delivery to children: a narrative review. Ann Transl Med. 2021 Apr;9(7):593. doi: 10.21037/atm-20-1682.
PMID: 33987291BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aslıhan Aydoğmuş, MSc
Martyr Prof. Dr. İlhan Varank Sancaktepe Education and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, PhD
Study Record Dates
First Submitted
February 24, 2023
First Posted
March 22, 2023
Study Start
October 1, 2021
Primary Completion
February 15, 2022
Study Completion
February 27, 2022
Last Updated
May 3, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share